LIPITOR, CRESTOR USE ASSOCIATED WITH CANCER. Somehow, some way, mainstream medicine has become enamored with this class of drugs called statins. We hand them out like candy to patients with high cholesterol, despite the fact that the research on their effectiveness, quite frankly, sucks. There has even been some talk about using them to lower rates of cancer (despite very limited evidence). However, this class of drugs, besides the fact that they don’t work very well, are associated with destruction of the muscles (a condition called rhabomyolosis) even without muscle pain! Far scarier, though, is the hint that there is actually an increased risk of cancer when we synthetically drive cholesterol levels too low with statins. So much for a $25 billion a year industry riding in on a white horse to save us all from heart attacks, huh? Read More…